SUPPRELIN Drug Patent Profile
✉ Email this page to a colleague
When do Supprelin patents expire, and what generic alternatives are available?
Supprelin is a drug marketed by Shire and Endo Operations and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in SUPPRELIN is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.
DrugPatentWatch® Generic Entry Outlook for Supprelin
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUPPRELIN?
- What are the global sales for SUPPRELIN?
- What is Average Wholesale Price for SUPPRELIN?
Summary for SUPPRELIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Clinical Trials: | 2 |
Patent Applications: | 4,740 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUPPRELIN |
What excipients (inactive ingredients) are in SUPPRELIN? | SUPPRELIN excipients list |
DailyMed Link: | SUPPRELIN at DailyMed |
![SUPPRELIN drug patent expirations Drug patent expirations by year for SUPPRELIN](/p/graph/s/t/SUPPRELIN-patent-expirations.png)
![Drug Prices for SUPPRELIN](/p/graph/drug-price/SUPPRELIN.png)
Recent Clinical Trials for SUPPRELIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Southwest Oncology Group | Phase 3 |
National Cancer Institute (NCI) | Phase 3 |
University of Colorado, Denver | Phase 2 |
US Patents and Regulatory Information for SUPPRELIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-001 | Dec 24, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Operations | SUPPRELIN LA | histrelin acetate | IMPLANT;SUBCUTANEOUS | 022058-001 | May 3, 2007 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-002 | Dec 24, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-003 | Dec 24, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUPPRELIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-001 | Dec 24, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-003 | Dec 24, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-002 | Dec 24, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUPPRELIN
See the table below for patents covering SUPPRELIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 533348 | ⤷ Sign Up | |
Ireland | 49822 | WATER-SOLUBLE PEPTIDES AFFECTING GONADAL FUNCTION | ⤷ Sign Up |
Germany | 3062118 | ⤷ Sign Up | |
Denmark | 149896 | ⤷ Sign Up | |
Austria | 2617 | ⤷ Sign Up | |
Japan | S565448 | ORGANIC COMPOUND | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |